APOLLOMICS INC
APLM · NASDAQ
Updated at 2026-10-14 09:20:46
- Today's High
- $21.32
- Today’s Low
- $21.17
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $21.17
- Previous Close
- $21.32
- Volume
- 1.74K
- Market Cap
- $62.14M
- P/E Ratio
- --
- EPS
- $-18.92
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 989 EAST HILLSDALE BLVD., FOSTER CITY, CA, UNITED STATES, 94404
- Country
- US
- Listing Date
- 2021-11-26
- Fiscal Year End
- December
- Shares Outstanding
- 2.2M
- CIK
- 0001944885
- Website
- www.apollomicsinc.com
Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. The company is headquartered in Foster City, California with additional locations in Hangzhou and Shanghai, China and Southbank, Australia.
Financial Metrics
Revenue
2026-03-31
--
2025-09-30
$8.5M
2025-03-31
-$785K
2024-12-31
-$1.57M
Operating Expenses
2026-03-31
-$1.13M
2025-09-30
$19.1M
2025-03-31
$7.62M
2024-12-31
$15.25M
Net Income
2026-03-31
$1.59M
2025-09-30
-$12.53M
2025-03-31
-$9.32M
2024-12-31
-$18.65M
Net Profit Margin
2026-03-31
--
2025-09-30
-147.48%
2025-03-31
1.18K%
2024-12-31
1.18K%
Earnings Per Share
2026-03-31
--
2025-09-30
$-11.37
2025-03-31
$-16.92
2024-12-31
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-03-31
$3.13M
2025-09-30
-$12.5M
2025-03-31
-$7.88M
2024-12-31
-$15.65M
Effective Tax Rate
2026-03-31
0.12%
2025-09-30
0%
2025-03-31
-1.4%
2024-12-31
-1.4%
| Item | 2026-03-31 | 2025-09-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | -- | $8.5M | -$785K | -$1.57M |
| Operating Expenses | -$1.13M | $19.1M | $7.62M | $15.25M |
| Net Income | $1.59M | -$12.53M | -$9.32M | -$18.65M |
| Net Profit Margin | -- | -147.48% | 1.18K% | 1.18K% |
| Earnings Per Share | -- | $-11.37 | $-16.92 | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $3.13M | -$12.5M | -$7.88M | -$15.65M |
| Effective Tax Rate | 0.12% | 0% | -1.4% | -1.4% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.